1. A Randomized Controlled, Treat-to-Target Study Evaluating the Efficacy and Safety of Insulin Glargine 300 U/mL (Gla-300) Administered Using Either Device-Supported or Routine Titration in People With Type 2 Diabetes. (September 2019) Authors: Davies, Melanie; Bain, Steve; Charpentier, Guillaume; Flacke, Frank; Goyeau, Harmonie; Woloschak, Michael; Hasslacher, Christoph; Vespasiani, Giacomo; Edelman, Steven Journal: Journal of diabetes science and technology Issue: Volume 13:Number 5(2019:Sep.) Page Start: 881 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Biosimilar Insulins Are Coming: The Top 10 Things you Should Know. Issue 3 (May 2014) Authors: Blumer, Ian; Edelman, Steven Journal: Postgraduate medicine Issue: Volume 126:Issue 3(2014) Page Start: 107 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Biosimilar insulins are coming: what they are, what you need to know. (November 2014) Authors: Edelman, Steven; Polonsky, William H.; Parkin, Christopher G. Journal: Current medical research and opinion Issue: Volume 30:Number 11(2014:Nov.) Page Start: 2217 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Chinese physician–patient communication at T2D diagnosis and links between patient-perceived communication quality and patient outcomes: Insights from the IntroDia™ study. (October 2016) Authors: Luo, Yingying; Ji, Linong; Down, Susan; Belton, Anne; Capehorn, Matthew; Polonsky, William H.; Edelman, Steven; Gamerman, Victoria; Emmerson, James; Alzaid, Aus Journal: Diabetes research and clinical practice Issue: Volume 120(2016)Supplement 1 Page Start: S58 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Effect of dapagliflozin as an adjunct to insulin over 52 weeks in individuals with type 1 diabetes: post-hoc renal analysis of the DEPICT randomised controlled trials. Issue 10 (October 2020) Authors: Groop, Per-Henrik; Dandona, Paresh; Phillip, Moshe; Gillard, Pieter; Edelman, Steven; Jendle, Johan; Xu, John; Scheerer, Markus F; Thoren, Fredrik; Iqbal, Nayyar; Repetto, Enrico; Mathieu, Chantal Journal: Lancet Issue: Volume 8:Issue 10(2020) Page Start: 845 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Efficacy and safety of a morning injection of insulin glargine 300 units/mL versus insulin glargine 100 units/mL in adult patients with type 1 diabetes: A multicentre, randomized controlled trial using continuous glucose monitoring. Issue 8 (9th May 2019) Authors: Pettus, Jeremy; Gill, Jasvinder; Paranjape, Sachin; Stewart, John; Malla, Shilpy; Edelman, Steven; Bergenstal, Richard M.; Bode, Bruce Journal: Diabetes, obesity & metabolism Issue: Volume 21:Issue 8(2019) Page Start: 1906 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Efficacy and safety of adding sotagliflozin, a dual sodium‐glucose co‐transporter (SGLT)1 and SGLT2 inhibitor, to optimized insulin therapy in adults with type 1 diabetes and baseline body mass index ≥ 27 kg/m2. Issue 3 (23rd December 2020) Authors: Danne, Thomas; Edelman, Steven; Frias, Juan Pablo; Ampudia‐Blasco, Francisco Javier; Banks, Philip; Jiang, Wenjun; Davies, Michael J.; Sawhney, Sangeeta Journal: Diabetes, obesity & metabolism Issue: Volume 23:Issue 3(2021) Page Start: 854 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. Making Insulin Accessible: Does Inhaled Insulin Fill an Unmet Need?. Issue 8 (August 2016) Authors: McGill, Janet; Ahn, David; Edelman, Steven; Kilpatrick, C.; Santos Cavaiola, Tricia Journal: Advances in therapy Issue: Volume 33:Issue 8(2016) Page Start: 1267 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. Physician experiences when discussing the need for additional oral medication with type 2 diabetes patients: Insights from the cross-national IntroDia® study. (February 2019) Authors: Down, Susan; Alzaid, Aus; Polonsky, William H.; Belton, Anne; Edelman, Steven; Gamerman, Victoria; Nagel, Friederike; Lee, Jisoo; Emmerson, James; Capehorn, Matthew Journal: Diabetes research and clinical practice Issue: Volume 148(2019) Page Start: 179 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. Physician–patient communication at diagnosis of type 2 diabetes and its links to patient outcomes: New results from the global IntroDia® study. (May 2017) Authors: Polonsky, William H.; Capehorn, Matthew; Belton, Anne; Down, Susan; Alzaid, Aus; Gamerman, Victoria; Nagel, Friedericke; Lee, Jisoo; Edelman, Steven Journal: Diabetes research and clinical practice Issue: Volume 127(2017) Page Start: 265 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗